CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 15h55 HE
|
Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 08h00 HE
|
Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
The Future of the Healthcare BPO Market - A $430.5 Billion Industry by 2030 - Surge in Demand for Specialized Solutions Fueled by the Rapid Growth of Digital Technology Usage
09 mai 2024 07h13 HE
|
Research and Markets
Dublin, May 09, 2024 (GLOBE NEWSWIRE) -- The "Healthcare BPO Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Service Type Coverage, Geographic Coverage...
US Healthcare BPO Market Share and Industry Trends (2019-2029) Featuring UnitedHealth Group, Cognizant, Accenture, Genpact, IBM, and More
02 avr. 2024 12h19 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "US Healthcare BPO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029" report has been added to ...
GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
05 déc. 2023 09h05 HE
|
GRI Bio, Inc.
Clinical development plan potentially leveraging 505(b)(2) regulatory pathway Currently available treatments for IPF are limited to only two approved drugs that come with significant...
Global Clinical Trial Patient Recruitment Services Market Expected to Reach $1.56 Billion by 2030, Driven by Growing Pharma Sector
18 oct. 2023 09h58 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age...
Global Healthcare BPO Market Forecast Report 2023-2030: Driving Forces - Rising Demands for Pharmacovigilance Propel Market
07 sept. 2023 06h38 HE
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Healthcare BPO Market by Payer Service, Pharmaceutical Service, Provider Service - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Global SYK Inhibitors Market & Clinical Trials Outlook Report 2023-2028: Potential $300 Million Opportunity, 1 Marketed Drug, Current & Forecast Sales, Competitive Landscape
24 mai 2023 06h08 HE
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...
QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center
23 mai 2023 08h00 HE
|
QSAM Biosciences Inc.
Austin, TX, May 23, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for...
Outlook on the SYK Inhibitors Global Market to 2028 - Players Include Calithera Biosciences, CrystalGenomics, CSPC Ouyi Pharmaceutical, Genosco and Hanmi Pharmaceutical
24 févr. 2023 05h18 HE
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Global SYK Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. This report contains a...